NCT00399906 - A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

April 30, 2009

Conditions

Psoriasis

Interventions

DRUG

BMS-582949

Tablets, Oral, Once daily, 12 weeks

DRUG

Placebo

Tablets, Oral, Once daily, 12 weeks

Trial Locations (21)

2217

Local Institution, Kogarah

3053

Local Institution, Carlton

3144

Local Institution, Malvern

4120

Local Institution, Greenslopes

5006

Local Institution, North Adelaide

20127

Local Institution, México

45190

Local Institution, Zapopan

64060

Local Institution, Monterrey

T3A 2N1

Local Institution, Calgary

T5K 1X3

Local Institution, Edmonton

V3R 6A7

Local Institution, Surrey

R2C 0N2

Local Institution, Winnipeg

A1B 3E1

Local Institution, St. John's

B3H 1Z4

Local Institution, Halifax

L6J 7W5

Local Institution, Oakville

M9W 4L6

Local Institution, Toronto

N2J 1C4

Local Institution, Waterloo

H3H 1V4

Local Institution, Montreal

G1V 4X7

Local Institution, Québec

H1S 3A9

Local Institution, Saint-Léonard

06780

Local Institution, Df